Emmanuelle Lamoureux

Through Innovation, Science & Industry discuss opportunities to enhance the Canadian life sciences sector including, biomanufacturing, partnerships, R&D investments. The Canada-European Union Comprehensive Economic and Trade Agreement (CETA) negotiations with respect to biopharmaceuticals and intellectual property right protection. Scientific Research and Experimental Development (SR&ED) Tax Incentive Program with regard to expansion of eligible expenditures to recognize the impact on innovation and the research and development (R&D) investment by the pharmaceutical industry in Canada. Science and Technology (S&T) Strategy with regard to ensuring that the implementation of that strategy encourages a public policy environment that attracts business investment in innovation and enhances the ability of Canadian industry to compete internationally. Representation with Ministry of Health and Public Service Procurement Canada to achieve emergency approval, procurement and utilization of the AZD1222 vaccine (Covishield) and long-acting antibody (LAAB) combination AZD7442 to fight the Covid-19 pandemic. Public policy issues related to Health Canada's review of NCE Patented Medicines Price Review Board (PMPRB) with regard to ensuring that PMPRB Guidelines, Policies and Procedures reflect PMPRB mandate to ensure that prices charged for patented medicines in Canada are not excessive and that potential changes consider impact to the pharmaceutical industry. Patented Medicines (Notice Of Compliance) Regulations with regard to ensuring that Canada's intellectual property (IP) laws and regulations are internationally competitive and continue to provide a stable and predictable business environment to encourage continued pharmaceutical investment in Canada. Patented Medicine Prices Review Board (PMPRB) with regard to ensuring guidelines also provide incentives for innovation through research and development in addition to PMPRB mandate of protection from excessive prices. National Pharmaceutical Strategy (NPS) with regard to ensuring development or implementation of any policies or programs include consultations with all affected stakeholders and focus on bettering access to medicines for Canadians. Cost Recovery Initiative, ensuring a framework where user fees adequately fund a safe and efficient review process. Canada's Food and Consumer Safety Action Plan with regard to ensuring that patient safety is a priority in a modern, efficient and internationally harmonized regulatory system that must be evidence-based, efficient and continuous while supporting timely access to innovative medicines and vaccines for Canadians, protecting intellectual property rights and preserving competitive research advantage. Canada's Access to Medicines Regime (CAMR) with regard to ensuring that the program allows for the delivery of timely access to needed medicines to the developing world supported by a business climate in Canada that continues to encourage research into further treatment and prevention of disease. Blueprint for Renewal with regard to ensuring a modern, efficient and internationally harmonized regulatory system that must be evidence-based, efficient and continuous while supporting timely access to innovative medicines and vaccines for Canadians, protecting intellectual property rights and preserving competitive research advantage.

Urging the federal government to lead the development of and work with the provinces and territories to implement a pan-Canadian digital health strategy. That the minister of health create a public awareness campaign to bring attention to the scourge of counterfeit prescription drugs That the federal government lead efforts to educate health-care workers on the importance of medication safety and deprescribing Support for regulated nurses working at full scope of practice Strengthening of programs and supports for vulnerable populations, including child health, senior's health and domestic maternal, newborn and child health strategy development. Strengthening and creating programs to support illness prevention and health promotion, long term care, palliative care, home and community care, affordable housing and other social determinants of health Strategies to address the health human resources crisis and nursing shortages across Canada, including providing funding to provinces and territories to help optimize workloads; financial supports for nurses and health-care workers such as loan forgiveness, tax incentives, retention bonuses for senior nurses; creating a mental health action plan for health-care workers; increasing training and education for health-care workers. Seeking funding for the Nursing the Future initiative Seek funding for nursing research Review the Income Tax Act, List of Authorized Medical Practitioners to ensure all categories of nurses are easily identified. Requesting the federal government to create a one-time fund of $1.2 billion over four years via the Primary Care Transition Fund II to expand the establishment of primary care teams in each province and territory, with a special focus in remote and underserved communities. Reinstate the position of a Chief Nursing Officer at the federal level, and support for CNO's in all provinces and territories. Provide funding for a comprehensive, universal, public, affordable prescription medication coverage that ensures access in all health-care settings based on need and not the ability to pay Protection of public from the ongoing and growing threat of antimicrobial resistance Pandemic Planning and COVID-19: ensure all nurses are properly supported and protecting by ensuring appropriate stockpiling of PPE, support for mental health while on the front lines, support for nursing students, increased access to education and training when return to work or working in various care setting while responding to a pandemic, ensuring appropriate guidelines and resources are disseminated and developed and ensure senior nurses are part of discussions and advisory review boards during pandemics in planning phases as well as post pandemic in the review. Nursing-entry to practice Invest in strategies to prevent and mitigate the health effects of climate change Influencing the Canada Health Transfer and Health Bilateral Agreements between the federal government and provinces and territories to urge governments to increase healthcare investments and invest in priority areas such as the health workforce, primary care, long-term care, mental health, data and virtual care, and surgeries and backlogs. Increasing federal health transfers to the provinces and territories via a demographic top-up to meet the needs of Canada's aging population. Increase support to Canadians who provide care for aging relatives and friends. Incorporate Primary Health Care (PHP) principles within a Health in All Policies approach Improving care in long-term care facilities through enhanced access to and provision of care from regulated nurses. Improve community- and home-based health promotion Improve access to primary care, home care, and palliative and end-of-life care for all people in Canada. Funding to support nursing certification across Canada to strengthen the safe delivery of expert care to older adults. Funding to support newly graduated nurses moving into professional practice for the first tim

Related to the life sciences, research and the digital ecosystems, we need to make sure that Canada creates an environment that is globally competitive Related to legislations on data privacy we need to make sure that Canada has legislations that are harmonized across provinces and federal governments as well as global standards. Patented Medicine Prices Review Board (PMPRB) amendments to the Patented Medicines Regulations and the related proposed guidelines.

Postal service disruption and the significant hardships these disruptions cause for Canadians and on health charities We ask the federal government to fund MS research in partnership with MS Canada, leveraging our connections and expertise to focus and further our understanding of MS, pursue leading-edge research on repair and regeneration, and explore prevention strategies, including targeting the Epstein-Barr virus (EBV). Safe Long-Term Care Act with respect to persons affected by MS National Housing Strategy with respect for persons with MS and other chronic conditions and disabilities Measures and funding for the charitable sector generally Home care, with respect to creation with provincial/ territorial governments programs relating to increased home care for persons with MS and other disabilities/ diseases and the support of caregivers Federal Budget: Allocate funding for the Canada Disability Benefit, the Employment Insurance Sickness Benefit; health research; access to treatment and care; and other budgetary policy as it relates to MS. Establishment of national strategy for neurological conditions, with respect to persons with MS and other neurological conditions. Employment Insurance sickness benefits, with respect to creation of flexible benefits for persons with MS and other episodic disabilities Disability Tax Credit with respect to making it refundable and ensuring eligibility for Canadians with episodic disabilities Comprehensive disability income programs, with respect to persons with MS and other chronic and episodic disabilities CIHR as it relates to federal funding & long term investment in health research Canada Pension Plan – Disability with respect to eligibility for persons with MS and other chronic and episodic disabilities Canada Health Transfer - health system funding transfer and agreements intended for provinces/territories to support the delivery of healthcare services, including MS care Canada Health Act and regulations, as it relates to long-term and home care Bill C-64, An Act Respecting Pharmacare with respect for persons with MS and other chronic conditions and disabilities Access to treatments as it relates to the current regulatory and price negotiation processes to enhance timely access to all Health Canada approved MS disease-modifying therapies, with respect to the National Strategy for Drugs for Rare Diseases and national pharmacare.

Communicating with ISED, regarding the receipt, allocation, and outcomes of funding received. Familiarizing Health Canada, ISED, and Members of Parliament about the work of the Praxis Spinal Cord Institute.

Universal Pharmacare - We advocate for universal national single payer program for prescription medication that would improve coverage across Canada and result in logistical efficiencies for the system. The importance of family medicine research and the impact it has on family medicine, primary care and the health care system. Want to ensure that family medicine research is acknowledged by federal officials as requiring sufficient supports. Scopes of Practice and collaborative care: support for enhanced intra- and inter-professional collaboration Public Health: support for family physician involvement in not only playing a pivotal role in the delivery of public health but also in planning for public health emergencies. Family physicians and their practices are essential in contributing pandemic response and are fundamental partners in supporting large-scale vaccination rollout in all provinces and territories - both as a source of accurate information and delivery points for vaccines. Patient's Medical Home (PMH): identified by its patients as the place that serves as the home base or central hub for the timely provision and/or coordination of all their health and medical care needs. Implementation of PMH is desired across Canada, including appropriate integration of virtual care and its application as a part of longitudinal relationship-based care in alignment with the PMH vision. Looking for support for and understanding of the role of social determinants of health (SDoH) and how these determinants, such as poverty, impact Canadians. The CFPC continues to call attention to SDoH, the role family physicians play and the expectations we have of federal decision-makers to acknowledge SDoH when crafting policies and programs. Indigenous Health: support for health care initiatives and education that improve health outcomes for Indigenous people of Canada and address the adverse effects of systemic racism, in line with the Truth and Reconciliation Commission of Canada’s calls for action. The CFPC maintains strong support of the proposed National Consortium for Indigenous Medical Education involving medical learners, educators, and physicians to ensure that training and continued professional development in caring for Indigenous patients are delivered through a lens of cultural humility and cultural safety. Health Human Resources: encourage support for the College of Family Physician's goal of every Canadian having their own family physician. The College of Family Physicians of Canada is also recommending increased federal support for a pan-Canadian health human resources plan to strengthen primary care. Investment into Primary Health Care Transition Fund would help improve Canada-wide access to family practices and allied primary care.